Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors

Journal of Neuro-Oncology

Volumn 52, Issue 1, 2001, Pages 57-62

  Woodburn, R T ^a   Azzarelli, B ^a   Montebello, J F ^a   Goss, I E ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Glial fibrillary acidic protein; Immunostaining; Ki 67; Medulloblastoma; p53; Synaptophysin

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; PROTEIN ANTIBODY; PROTEIN P53; SYNAPTOPHYSIN;

ADOLESCENT; ADULT; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CORRELATION FUNCTION; DISEASE MARKER; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; PREDICTION; PROGNOSIS; STATISTICAL ANALYSIS;

ADOLESCENT; BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFANT; KI-67 ANTIGEN; MALE; MEDULLOBLASTOMA; NEUROECTODERMAL TUMORS, PRIMITIVE; PROGNOSIS; STAINING AND LABELING; SURVIVAL ANALYSIS; SYNAPTOPHYSIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034972938     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010691330670     Document Type: Article

References (32)

1. Trends in cancer incidence among children in the US
2. The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone
3. Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I)
4. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma: A Pediatric Oncology Group Study
5. Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma
6. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group Study
7. Medulloblastoma: Long-term results for patients treated with definitive radiation therapy during the computed tomography era
8. The prognostic significance of the biomarkers p21 (WAF1/CIP1), p53, and bcl-2 in laryngeal sqamous cell carcinoma
9. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder
10. Pediatric medulloblasoma: Prognostic value of p53, bcl-2, Mib-1, and microvessel density
11. p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis
12. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
13. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms
14. Monoclonal antibodies against recombinant parts of the KI-67 anigen (MIB1 and MIB3) detet proliferating cells in microwave-processed formalin-fixed paraffin sections
15. Ki-67 antigen expression as a prognostic factor primary and recurrent astrocytomas
16. A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis of synaptophysin expression
17. Primitive neuroectodermal tumors including the medulloblastoma: Glial differentiation signaled by immunoreactivity for GFAP is restricted to the prue desmoplastic medulloblastoma ('arachnoidal sarcoma of the cerebellum')
18. Glial fibrillary acidic protein in medulloblastoma
19. Neuron-associated class III beta-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: A clinicopathologic analysis of 37 cases
20. The prognostic significance of glial fibrillary acidic protein staining in medulloblastoma
21. Prognostic importance of cellular differentiation in medulloblastoma of childhood
22. Prognostic implications of chromosome 17p deletions in human medulloblastomas
23. Molecular analyses of childhood primitive neuroectodermal tumors defines markers associated with poor outcome
24. Prognostic factors in medulloblastoma, including DNA ploidy
25. The p53 tumor suppressor gene
26. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
27. The p53 Proto-oncogene can act as a suppressor of transformation
28. Essential role for p53-mediated transcription in E1A-induced apoptosis
29. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53
30. Mutant p53 DNA clones from human colon carcinomas cooperated with ras in transforming primary rat cells: A comparison of the 'hot spot' mutant phenotypes
31. p53 gene satus in endometial carcinoma showing diffuse positivity for p53 protein by immunohistochemical analysis
32. Accumulation of wild-type p53 in astrocytoms is associated with increased p21 expression